Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative chemoradiotherapy using IMRT for locally advanced rectal cancer
jRCTs051180039Completed
- Sponsor
- Japan Society of Clinical Oncology
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tegafur and irinotecan in rectal cancer, sponsored by Japan Society of Clinical Oncology. Primary endpoint: Grade 2 acute gastrointestinal toxicity rate. Started Feb 2017; status: completed.
02
Drugs
tegafuririnotecan
03
Conditions
rectal cancer
Beyond the preview
Go deeper on jRCTs051180039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180039.